Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00648635 · ClinicalTrials.gov registry record
Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations
A clinical trial of Rectal Cancer, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 116
- Enrollment target
- 1
- Study location
NCT00648635 is a study of Rectal Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 116 participants, below the 3,165-participant average among 70 other Rectal Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00648635, a study of Rectal Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn how the treatment given to patients with recurrent rectal cancer affects their well being and quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2008-03-12 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00648635
The ClinicalTrials.gov registry entry for NCT00648635 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,165-participant average among 70 other Rectal Cancer trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT00648635 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00648635 about?
NCT00648635 is a clinical study titled "Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations". The goal of this study is to learn how the treatment given to patients with recurrent rectal cancer affects their well being and quality of life.
What is the current status of trial NCT00648635?
This trial is currently active not recruiting. The enrollment target is 116 participants. The study started on 2008-03-12. Estimated completion is 2027-09-30.
What conditions does trial NCT00648635 study?
This clinical trial studies the following conditions: Rectal Cancer.
What interventions are being tested in trial NCT00648635?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00648635?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00648635 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
RECRUITING · Phase 1
-
Exosomes in Rectal Cancer
RECRUITING
-
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
RECRUITING · Phase 2
-
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
RECRUITING · Phase 2
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.